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Abstract: Model organisms are an essential component of biological and biomedical research that
can be used to study specific biological processes. These organisms are in part selected for facile
experimental study. However, just as importantly, intensive study of a small number of model
organisms yields important synergies as discoveries in one area of science for a given organism shed
light on biological processes in other areas, even for other organisms. Furthermore, the extensive
knowledge bases compiled for each model organism enable systems-level understandings of these
species, which enhance the overall biological and biomedical knowledge for all organisms, including
humans. Building upon extensive genomics research, we argue that the time is now right to focus
intensively on model organism metabolomes. We propose a grand challenge for metabolomics
studies of model organisms: to identify and map all metabolites onto metabolic pathways, to develop
quantitative metabolic models for model organisms, and to relate organism metabolic pathways
within the context of evolutionary metabolomics, i.e., phylometabolomics. These efforts should focus
on a series of established model organisms in microbial, animal and plant research.
Keywords: Escherichia coli; Saccharomyces cerevisiae; Caenorhabditis elegans; Danio rerio; Daphnia magna;
Drosophila melanogaster; Mus musculus; Arabidopsis thaliana; Oryza sativa; Solanum lycopersicum
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1. The Importance of Model Organisms
Model organisms are an essential component of biological, biomedical and environmental research
that can be used to study specific biological processes. They represent carefully selected biosystems that
are relatively simple to manipulate, are relatively inexpensive, and consequently are widely available
and accessible to researchers. These biosystems often have short generation times and are easy to
propagate. Model organisms can include vertebrate and invertebrate animals, plants and microbes.
Intensive studies of a moderate number of key organisms yield research efficiencies, and is leading
to systems-level understandings of these organisms. Furthermore, knowledge gleaned for model
organisms can be transferred to related organisms. The most cited organisms within Google scholar
comprise Homo sapiens, Mus musculus, Arabidopsis thaliana, Escherichia coli, Saccharomyces cerevisiae,
Caenorhabditis elegans and Drosophila melanogaster. Five of these non-human species form a subset of the
13 model organisms listed by the US National Institutes of Health (NIH).
Much of what we know about biological processes, whether they be involved in human disease,
pharmacology, toxicology, plant physiology, evolution, or ecology, has been learnt through basic
research into model organisms. For example, major insights into developmental biology have been
gained from research on fruit flies (in particular D. melanogaster). It is an ideal species for this purpose
as it is easy to maintain, small, breeds rapidly, and lays many eggs. In addition, D. melanogaster has
many characterized visible mutations, only four chromosomes and a well-annotated genome sequence.
These resources have led to its rapid establishment as one of the most widely used model organisms
with over 91,000 references catalogued in PubMed. C. elegans, a free-living transparent nematode, has
also become an excellent model for developmental biology. Horvitz and Sulston followed the fate of
all cell divisions from a fertilized egg to an adult hermaphrodite [1], enhancing our understanding
of normal development and leading to the discovery of apoptosis. Increasingly this species is being
used as a model organism in terrestrial toxicology. Another invertebrate, the water flea Daphnia,
is the most recently listed NIH model organism. It has long been an established sentinel species
in freshwater ecology and regulatory toxicology. Daphnia’s listing by the NIH followed from the
discovery that its genome is highly responsive to environmental stresses [2], and hence can serve
as a model for both human-environment interactions as well as in freshwater toxicology. Mouse
models are of course widely used in biomedical research, with €550 M European Commission funding
invested into research projects using this model between 1998 and 2010 [3]. Zebrafish (Danio rerio)
represent another important vertebrate model that shares a high degree of genetic and organ system
homology to humans. Advantages for the use of zebrafish, in comparison to mice, include the ability
to house zebrafish in more natural conditions than is possible to simulate for mammals, ease of genetic
manipulation (e.g., through absorption of chemical mutagens added to their water), much higher
fecundity, rapid growth and development, and transparency through early adulthood allowing the
use of imaging modalities for metabolic and phenotypic assessments. This species has wide-ranging
applications as a model from biomedical to environmental research. Within the plant kingdom
A. thaliana, a member of the mustard (Brassicaceae) family, is widely used as a model organism in plant
biology, including plant-pathogen interactions, a topic of wide-ranging importance in times of concern
about feeding a growing population on the planet.
While seemingly disparate, research into bacteria, yeast, insects, worms, fish, rodents and
plants has shown that the core biochemical operating principles have been conserved across all
living organisms. It is this very fact that justifies how findings derived from non-mammalian
animals, for example, can shed light on biological processes in humans. For the specific case
of metabolic biochemistry, primary metabolites have traditionally been defined are those directly
involved in conserved processes necessary for life such as energy generation, growth, development
and reproduction, and hence are typically present across many taxa. In contrast, secondary metabolites
have traditionally been defined as not being directly involved in conserved processes and instead
have a role(s) in more specialized metabolism. Secondary metabolites are vastly more chemically
diverse and occur widely in plants, fungi and microbes and are of huge importance to many industries
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(e.g., the pharmaceutical, nutraceutical and agrochemical sectors). A systematic and comparative study
of the metabolism of several model organisms will help us to better understand universally conserved,
as well as more specialized pathways, which ultimately should lead to a deeper understanding of
metabolites beyond their simple categorization into “primary” and “secondary”.
2. Growth of ’Omics Research into Model Organisms
The sequencing of organism genomes, exemplified by the Human Genome Project that was
launched in 1990, represents one of the greatest endeavors in the history of science. This project and
associated technologies helped to drive the sequencing of many other organisms and consequently
the continued growth of model organism research, with scientific communities further expanding
around key species as their genomes were sequenced. For example, considering the model organisms
introduced above, A. thaliana was the first plant genome to be sequenced in 2000 [4] and there is now
a vast array of resources and many are outlined in the Arabidopsis Information Resource [5]. The
draft mouse genome was published shortly after the human genome in 2002 [6]. The sequencing of
Daphnia pulex was the first of any crustacean, revealing that it contained many more genes than the
human genome [2]. However, these activities have not solely been driven by the sequencing of the
human genome. As noted by Wilson and others, the C. elegans genome-sequencing project provided
an important foundation upon which to develop the Human Genome Project [7]. Furthermore,
the ENCODE project sponsored by National Human Genome Research Institute (NHGRI) [8] to
accelerate the annotation of functional non-coding portions of the human genome was facilitated and
complemented by the modENCODE project that focused on similar genomic regions in C. elegans and
D. melanogaster [9]. By comparison to the human reference genome, approximately 70% of human
genes have at least one zebrafish ortholog [10]. The importance of these model organisms, and the
growth of genomics research focused on these species, cannot therefore be overstated.
Beyond genomics, the Human Proteome Organization (HUPO) has launched an initiative on
Model Organism Proteomes (iMOP). The overarching aim of iMOP is to create a global network of
experimental and bioinformatics groups interested in model organism proteomes, to standardize the
protocols and standards for model organism proteome characterization, and to make optimum use of
the proteomics data once acquired [11]. Collectively, these large-scale data generation experiments have
fed the development of new computational techniques for genome-scale metabolic modeling. From
annotated genomes we can now computationally infer the reaction network of an organism [11], which
in turn can be used to develop a steady-state metabolic model for that organism [12]. Genome-scale
metabolic models have now been developed for the model organisms E. coli [13,14] and S. cerevisiae [15],
as well as for humans [16]. These models can accurately predict gene knock-out phenotypes, growth
rates under different nutrient conditions, and disease phenotypes.
The field of metabolomics has truly come of age and is making a significant impact in a wide
range of fields from biomedicine and pharmacology to agriculture [17–20]. Several metabolomics
studies have revealed an unexpectedly large uncharted landscape of unknown metabolites in the
organisms studied to date [21–23]. These metabolites, and the biochemical pathways that produce them,
represent a huge opportunity for new biological discovery. It was in response to this challenge that the
international Metabolomics Society launched a Metabolite Identification task group in 2013 [24], with
goals to develop robust reporting standards for metabolite identification and to advertise best-practice
to the metabolomics community using a range of analytical approaches [25–28]. The challenge of
identifying all metabolites in all sample types is currently—and into the foreseeable future—not
achievable. This paucity of peak identification is often, and justifiably, highlighted as one of the critical
weaknesses of metabolomics science by those outside of the metabolomics community. Hence it is
vital that this challenge is confronted immediately, drawing upon broad international expertise.
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3. Launch of the Model Organism Metabolomes Task Group
To leverage both the international studies of model organisms and the rapidly growing field of
metabolomics, as well as to add momentum to more general efforts to identify metabolites, we propose
that the community should focus and extend research activities specifically on the identification of
Model Organism Metabolomes (MOMs). In June 2015, the authors of this paper met in San Francisco
and launched the Metabolomics Society’s Model Organism Metabolomes (MOM) task group, and have
subsequently developed a grand challenge as well as multiple aims for the metabolomics and related
communities. The grand challenge is to identify and map all metabolites onto metabolic pathways, to develop
quantitative metabolic models for many model organisms (Table 1), and to relate organism metabolic pathways
within the context of evolutionary metabolomics, i.e., phylometabolomics. More specifically, we define
phylometabolomics as the comparative analysis of the evolution of metabolism and metabolic networks
in a phylogenetic context. Such an approach is dependent upon our ability to identify the metabolomes
of multiple species and would enable us to study, for example, the roles of ancestral constraint,
common ancestry and the evolutionary convergence of metabolism. In turn, such knowledge has
practical applications, for example to predict human or environmental toxicity through the discovery of
evolutionarily conserved molecular mechanisms of toxic responses, or to highlight metabolic pathway
characteristics of species longevity [29]. We recommend that these efforts to identify and map all
metabolic pathways should focus initially on a series of established model organisms in microbial,
animal and plant research (Table 1). Furthermore, these efforts will exploit established tools from
all of the model organisms to provide novel biological and bioinformatic approaches for metabolite
identification through genetic manipulations, including gene knockouts, transgenics, mutations, and
large panels of recombinant inbred lines. These genetic manipulations are not ethically possible in
humans but will provide information that can be applied to humans and human disease.
Table 1. Prioritized list of model organisms that the new MOM task group recommend for deep
investigations of their metabolomes.
Kingdom Latin Name Common Name
Bacteria Escherichia coli -
Fungi Saccharomyces cerevisiae yeast
Animal (invertebrate)
Caenorhabditis elegans nematode
Daphnia magna water flea





Arabidopsis thaliana ** thale cress
Medicago truncatula barrel medic, model legume
Oryza sativa rice
Solanum lycopersicum tomato
* International Drosophila Metabolomics Curation Consortium [30]; ** Metabolomics subcommittee (chaired by
Kazuki Saito) within the Multinational Arabidopsis Steering Committee [31].
The aims of the Model Organism Metabolomes task group are:
‚ To integrate disparate model organism-focused research groups into a model organism
metabolomes community, to promote interactions between these groups, and to stimulate
joint initiatives.
‚ To share, discuss and coordinate analytical strategies to progress the annotation and identification
of model organism metabolomes (including polar metabolites and lipids), linking with the efforts
of the Metabolomics Society’s Metabolite Identification task group, to generate best-practice
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strategies. In addition, to determine quantifiable ranges of primary and secondary metabolite
levels measured in the model organisms under differing conditions, e.g., diet and environment.
‚ To share, discuss and coordinate bioinformatic strategies, data standards and databases
for the curation, analysis and visualization of model organism metabolomes, to generate/
best-practice strategies.
‚ To catalyse the integration of metabolome data with the huge battery of existing information and
knowledge of model organisms, thereby linking metabolic data with other data types including
other ’omics data.
‚ To catalyze the integration of phylometabolomic data into a framework for understanding the
evolution of metabolic networks and also how these respond to stressors, and to explore linkages
between the phenotype(s) induced by these stressors.
‚ To support the development of quantitative metabolic models for model organisms.
‚ To promote the use of model organism metabolomes in systems biology education for training
future ’omics scientists.
Meetings that include a focus on model organism metabolome identification include both
past events (e.g., Genetics Society of America Drosophila conference 2014, Metabolomics Society
conference 2015) as well as proposed future events (e.g., the Metabolomics Society’s 2016 conference
and beyond, Daphnia Genomics Consortium conferences, GSA Model Organism conferences). To
initiate more immediate discussions within the community, the MOM task group has established
a forum at http://metabolomics-forum.com. In addition, we recommend either the MetaboLights
repository [32] based at EMBL-EBI [33] or Metabolomics Workbench [34,35] for data deposition related
to model organism species. Furthermore, we recommend resources such as the BioCyc and Pathways
Tools to build curated predicted metabolic networks from annotated genome sequences for model
organisms [36,37]. We welcome the opportunity to dialogue with the international metabolomics
community, to discuss how to address the aims above, and together to advance the annotation and
identification of model organism metabolomes.
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